<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0020">
 <label>20.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Woods</surname>
    <given-names>CW</given-names>
   </name>, 
   <name name-style="western">
    <surname>Sanchez</surname>
    <given-names>AM</given-names>
   </name>, 
   <name name-style="western">
    <surname>Swamy</surname>
    <given-names>GK</given-names>
   </name>, 
   <name name-style="western">
    <surname>McClain</surname>
    <given-names>MT</given-names>
   </name>, 
   <name name-style="western">
    <surname>Harrington</surname>
    <given-names>L</given-names>
   </name>, 
   <name name-style="western">
    <surname>Freeman</surname>
    <given-names>D</given-names>
   </name>, 
   <name name-style="western">
    <surname>Poore</surname>
    <given-names>EA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Slifka</surname>
    <given-names>DK</given-names>
   </name>, 
   <name name-style="western">
    <surname>Poer DeRaad</surname>
    <given-names>DE</given-names>
   </name>, 
   <name name-style="western">
    <surname>Amanna</surname>
    <given-names>IJ</given-names>
   </name>, et al
  </person-group>
  <article-title>An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults</article-title>. 
  <source>Vaccine</source>. 
  <year>2019</year>;
  <volume>S0264–410X</volume>:
  <fpage>31699</fpage>–
  <lpage>702</lpage>.
 </mixed-citation>
</ref>
